期刊文献+

Survivin基因启动子区-31C>G功能性多态与卵巢癌遗传易感性的关联研究 被引量:2

The correlation between Survivin promoter-31C>G polymorphism and genetic susceptibility to ovarian cancer
在线阅读 下载PDF
导出
摘要 目的探讨Survivin基因启动子区域-31C>G多态(single nucleotide polymorphism,SNP)与中国北方汉族人群卵巢上皮性癌(epithelial ovarian cancer,EOC)发病易感性的关系。方法采用聚合酶链式反应-连接酶检测反应(polymerase chain reaction-ligase detection reac-tion,PCR-LDR)技术检测了138例EOC患者和138例健康对照个体survivin基因启动子区-31C>G多态的基因型。结果病例组三种基因型频率(28.3%、47.1%和24.6%)与对照组(17.4%、46.4%和36.2%)比较,差异有统计学意义(χ2=6.63,P=0.04),病例组C/C基因型的频率明显高于对照人群(P<0.01);与G/G基因型相比,携带C/C基因型能显著增加EOC的发病风险(OR=2.39,95%CI=1.22~4.67)。结论 Survivin基因-31C>G多态与EOC发病风险有关,-31G变异基因型可能成为预测中国北方汉族人群卵巢上皮性癌发病风险的独立危险因素。 Objective To investigate the correlation between Survivin gene-31C>G polymorphism and genetic susceptibility to epithelial ovarian cancer(EOC) in Han people in north of China.Methods The genotypes of-31C>G polymorphism were detected by polymerase chain reaction-ligase detection reaction(PCR-LDR) in 138 EOC patients and 138 healthy subjects.Results The three kinds of genotype frequencies of-31C>G polymorphism in EOC group(28.3%,47.1%,24.6%) were significantly different from those in control group(17.4%,46.4%,36.2%,P<0.05),and the frequency of C/C gene type in EOC group was significantly higher than that in control group(P<0.01).As compared with G/G genotype,C/C genotype could obviously increase EOC onset risk(OR=2.39,95% CI=1.22~4.67).Conclusion Survivin gene-31C>G polymorphism is related with EOC onset risk,and 31G mutant gene type may be an independent risk factor for predicting EOC onset risk in Han people in north of China.
出处 《河北医药》 CAS 2012年第15期2253-2255,共3页 Hebei Medical Journal
关键词 SURVIVIN 基因多态性 卵巢上皮性癌 遗传易感性 Survivin gene polymorphism epithelial ovarian cancer genetic susceptibility
  • 相关文献

参考文献15

  • 1Li F, Brattain MG. Role of the Survivin gene in pathophysiology. Am J Patho1,2006,169 : 1-11.
  • 2夏爽,傅芬.COX-2、Survivin蛋白在卵巢上皮性癌中的表达及与临床病理因素的关系[J].江西医学院学报,2006,46(6):70-73. 被引量:3
  • 3高庆,邢兰英,王咏雪.P-糖蛋白、Survivin蛋白在卵巢上皮性癌中的表达及其与卵巢癌耐药的关系[J].西安交通大学学报(医学版),2007,28(5):578-581. 被引量:8
  • 4马志松,黄永生,苏悦.卵巢上皮性癌组织中survivin与p53表达的研究[J].实用医药杂志,2011,28(4):301-302. 被引量:6
  • 5Jang JS, Kim KM, Kang KH, et al. Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer,2008,60:31-39.
  • 6Xu Y, Fang F, Ludewig G, et al. A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Bio1,2004,23:527-537.
  • 7Qin C, Cao Q, Li P, et al. Functional promoter-31G > C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chi- nese population. PLoS One ,2012,7 : e28829.
  • 8Jaiswal PK, Goel A, Mandhani A, et al. Functional polymorphisms in pro- moter survivin gene and its association with susceptibility to bladder canc- er in North Indian cohort. Mol Biol Rep,2012,39:5615-5621.
  • 9Borges Bdo N, Burbano RR, Harada ML. Survivin-31 C/G polymorphism and gastric cancer risk in a Brazilian population. Clin Exp Med, 2011, 11:189-193.
  • 10Yang X, Xiong G, Chen X, et al. Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma. J Cancer Res Clin Onco1,2009,135 : 1341-1349.

二级参考文献48

  • 1楼伟珍,沈铿,张羽,郎景和.卵巢上皮性癌中环氧合酶2的表达及意义[J].中华医学杂志,2004,84(16):1374-1376. 被引量:3
  • 2伍成奇,刘林嶓,李珊珊,陈言汤,牛扶幼,郝媛媛.病理性瘢痕组织中Survivin、P33ING1、Caspase-3蛋白的表达[J].郑州大学学报(医学版),2006,41(6):1038-1041. 被引量:1
  • 3Landen Jr CN,Birrer MJ,Sood AK.Early eventes in the pathogenesis of epithelial ovarian cancer.[J].J Clin Oncol,2008,26:995-1005.
  • 4Duffy MJ,Donovan N,Brennan DJ,et al.Survivin:a promising tumor biomarker[J].Cancer Lett,2007,249(l):49-60.
  • 5Kleinberg L,Flarenes VA,Silins I,et al.Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.Cancer,2007,109(2):228,238.
  • 6Yamashita S,Masuda Y,Kunzaki T,et al.Survivin expression predicts early recurrence in early-stage breast cancer.Anticancer Res,2007,27:2803-2808.
  • 7Dan HC,Jiang K,Coppola D,et al.Phosphatidylinositol-3-OH kinase/AKT and survivin pathways as critical targets for geranylger-anyltransferase Ⅰ inhibitor-induced apoptosis[J].Oncogene,2004,23930:706-715.
  • 8Hoffman WH,Biade S,Zilffou JT,et al.Transcriptional respression of the anti-apoptotic survivin gene by wild type p53.J Biol Chen,2002,277:3247-3257.
  • 9Xiaoya Y,Gang X,Xuedan C,et al.Survivin expression in esophageal cancer:correlation with p53 mutations and promoter polymorphism.Diseases of the Esophagus,2009,22(2):223-230.
  • 10Nabilsi NH,Broaddus RR,Loose DS.DNA methylation inhibits p53-mediated survivin expression.Oncogene,2009,28:2046-2050.

共引文献26

同被引文献4

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部